Klinické studie

 

CAPURSO, Lucio. Thirty years of Lactobacillus rhamnosus GG: a review. Journal of clinical gastroenterology, 2019, 53: S1-S41.

STEELE, Chloe. Lactobacillus rhamnosus GG: A review of clinical use and efficacy. Nutritional Med J, 2022, 1.3: 70-116.

LIU, Huazi; FEI, Qiang; YUAN, Tianming. The effectiveness of Lactobacillus rhamnosus GG in the treatment of infantile colic: a systematic review and meta-analysis. Translational Pediatrics, 2024, 13.8: 1415.

BLAABJERG, Sara; ARTZI, Daniel Maribo; AABENHUS, Rune. Probiotics for the prevention of antibiotic-associated diarrhea in outpatients—a systematic review and meta-analysis. Antibiotics, 2017, 6.4: 21.

PAGNINI, Cristiano, et al. Safety and potential role of Lactobacillus rhamnosus GG administration as monotherapy in ulcerative colitis patients with mild–moderate clinical activity. Microorganisms, 2023, 11.6: 1381.

SZAJEWSKA, Hania; HOJSAK, Iva. Health benefits of Lactobacillus rhamnosus GG and Bifidobacterium animalis subspecies lactis BB-12 in children. Postgraduate medicine, 2020, 132.5: 441-451.

MERENSTEIN, D., et al. Bifidobacterium animalis subsp. lactis BB-12 protects against antibiotic-induced functional and compositional changes in human Fecal microbiome. Nutrients 13 (8), 2814 [online]. 2021.

NOCERINO, Rita, et al. The therapeutic efficacy of Bifidobacterium animalis subsp. lactis BB‐12® in infant colic: A randomised, double blind, placebo‐controlled trial. Alimentary pharmacology & therapeutics, 2020, 51.1: 110-120.

PINO, Alessandra, et al. Lacticaseibacillus rhamnosus CA15 (DSM 33960) as a candidate probiotic strain for human health. Nutrients, 2022, 14.22: 4902.

PINO, Alessandra, et al. Detection of vaginal lactobacilli as probiotic candidates. Scientific reports, 2019, 9.1: 3355.

RAPISARDA, Agnese Maria Chiara, et al. Lacticaseibacillus rhamnosus CA15 (DSM 33960) strain as a new driver in restoring the normal vaginal microbiota: A randomized, double-blind, placebo-controlled clinical trial. Frontiers in Surgery, 2023, 9: 1075612.

MARCOTTE, Harold, et al. Characterization and complete genome sequences of L. rhamnosus DSM 14870 and L. gasseri DSM 14869 contained in the EcoVag® probiotic vaginal capsules. Microbiological research, 2017, 205: 88-98.

ZENG, Zhu; ZUO, Fanglei; MARCOTTE, Harold. Putative adhesion factors in vaginal Lactobacillus gasseri DSM 14869: functional characterization. Applied and environmental microbiology, 2019, 85.19: e00800-19.

DASKALAKIS, George J.; KARAMBELAS, Alexis K. Vaginal probiotic administration in the management of preterm premature rupture of membranes. Fetal Diagnosis and Therapy, 2017, 42.2: 92-98.

PENDHARKAR, Sonal, et al. Vaginal colonisation by probiotic lactobacilli and clinical outcome in women conventionally treated for bacterial vaginosis and yeast infection. BMC infectious diseases, 2015, 15.1: 255.

LARSSON, Per-Göran, et al. Extended antimicrobial treatment of bacterial vaginosis combined with human lactobacilli to find the best treatment and minimize the risk of relapses. BMC infectious diseases, 2011, 11.1: 223.